Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 151,844 | 144,531 | 156,333 | 126,588 | 94,507 |
| Marketable Securities | 72,236 | 114,710 | 21,864 | 12,520 | 15,177 |
| Receivables | 138,036 | 115,469 | 88,975 | 78,930 | 66,390 |
| Inventories | 153,741 | 105,833 | 103,584 | 92,807 | 96,831 |
| TOTAL | $534,071 | $489,600 | $378,319 | $318,119 | $279,682 |
| Non-Current Assets | |||||
| PPE Net | 297,345 | 282,746 | 238,266 | 244,244 | 260,055 |
| Investments And Advances | 10,996 | 15,212 | 2,414 | 3,985 | 0 |
| Other Non-Current Assets | 735,058 | 725,354 | 122,988 | 105,181 | 91,499 |
| TOTAL | $1,043,399 | $1,023,312 | $363,668 | $353,410 | $351,554 |
| Total Assets | $1,577,470 | $1,512,912 | $741,987 | $671,529 | $631,236 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 234 | 436 | 3,046 | 2,202 | 12,263 |
| Accounts payable and accrued liabilities | 157,057 | 93,366 | 84,242 | 89,545 | 95,504 |
| Accrued Expenses | N/A | 126,090 | N/A | N/A | N/A |
| TOTAL | $173,759 | $225,407 | $94,862 | $103,810 | $112,201 |
| Non-Current Liabilities | |||||
| Long Term Debt | 601,630 | 589,579 | 72,839 | 74,776 | 34,186 |
| Other Non-Current Liabilities | 69,783 | 58,505 | 45,484 | 45,702 | 35,691 |
| TOTAL | $671,413 | $648,084 | $118,467 | $122,197 | $70,312 |
| Total Liabilities | $845,172 | $873,491 | $213,329 | $226,007 | $182,513 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,650 | 48,096 | 47,897 | 48,147 | 47,433 |
| Common Shares | 6 | 6 | 6 | 6 | 5 |
| Retained earnings | 568,787 | 409,268 | 271,723 | 180,337 | 117,773 |
| Other shareholders' equity | -8,895 | -8,909 | -8,148 | -7,244 | 42,884 |
| TOTAL | $732,298 | $639,421 | $528,658 | $445,522 | $448,723 |
| Total Liabilities And Equity | $1,577,470 | $1,512,912 | $741,987 | $671,529 | $631,236 |